(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1508538

輸血診断市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年

Blood Transfusion Diagnostics Market (Product Type: Instruments, and Kits and Reagents; and Application: Blood Grouping, and Disease Screening) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 225 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
輸血診断市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年
出版日: 2024年05月16日
発行: Transparency Market Research
ページ情報: 英文 225 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

輸血診断市場- 調査範囲

TMRの調査レポート「輸血診断の世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の輸血診断市場の収益と予測を提供しています。また、2024年から2034年までの世界の輸血診断市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、輸血診断市場を理解しました。

市場スナップショット
2023年の市場規模 46億米ドル
2034年の市場規模 77億米ドル
CAGR 4.9%

本レポートでは、世界の輸血診断市場の競合情勢について掘り下げています。世界の輸血診断市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の輸血診断市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測, 2020-2034年

第5章 主要洞察

  • 血液疾患の疫学と輸血イベントの発生率
  • 輸血製品の価格分析
  • 政府調達政策
  • 主要な業界イベント（パートナーシップ、コラボレーション、製品承認、合併と買収、資金調達と投資）
  • COVID-19パンデミックの影響

第6章 世界の市場分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：製品タイプ別, 2020-2034年
    • 機器
      • 血液型判定機器
      • その他
    • キットと試薬
      • 血液型判定キットおよび試薬
      • その他
  • 製品タイプ別の市場の魅力

第7章 世界の市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：用途別, 2020-2034年
    • 血液型
      • ABO式血液型
      • Rh血液型
      • 赤血球抗体スクリーニング
      • 拡張表現型解析
      • クロスマッチングテスト
    • 病気のスクリーニング
      • 分子疾患スクリーニング
      • 血清学的疾患スクリーニング
  • 用途別の市場の魅力

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：エンドユーザー別, 2020-2034年
    • 血液銀行
    • 献血・輸血センター
    • その他
  • エンドユーザー別の市場の魅力

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域

第12章 アジア太平洋地域の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 企業プロファイル
    • Grifols, S.A.
    • Werfen, S.A.
    • QuidelOrtho Corporation
    • Abbott
    • Bio-Rad Laboratories Inc.
    • F. Hoffman La Roche Ltd.
    • AliveDx Holdings Finance Company Ltd
    • BAG Diagnostics GmbH
    • Diasorin S.p.A.
    • Prestige Diagnostics U.K. Ltd.
    • Atlas Medical GmbH
    • Lorne Laboratories Limited
図表

List of Tables

  • Table 01: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 02: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instrument, 2020-2034
  • Table 03: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 04: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 05: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 06: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 07: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 08: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 09: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 10: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 11: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 12: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 13: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 14: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 15: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 16: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 17: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 19: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 20: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 21: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 22: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 23: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 24: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 25: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 27: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 28: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 29: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 30: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 31: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 32: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 33: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 34: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 35: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 36: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 37: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 38: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 39: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 40: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 41: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 42: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 43: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 44: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 45: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 46: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 47: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 48: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Blood Transfusion Diagnostics Market Value Share, by Product Type, 2023
  • Figure 03: Global Blood Transfusion Diagnostics Market Value Share, by Application, 2023
  • Figure 04: Global Blood Transfusion Diagnostics Market Value Share, by End-user, 2023
  • Figure 05: Global Blood Transfusion Diagnostics Market Value Share, by Region, 2023
  • Figure 06: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 07: Global Blood Transfusion Diagnostics Market Share Analysis, by Product Type, 2023
  • Figure 08: Global Blood Transfusion Diagnostics Market Share Analysis, by Product Type, 2034
  • Figure 09: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 10: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Instruments, 2020-2034
  • Figure 11: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Instruments, 2023 and 2034
  • Figure 12: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Kits and Reagents, 2020-2034
  • Figure 13: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Kits & Reagents, 2023 and 2034
  • Figure 14: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 15: Global Blood Transfusion Diagnostics Market Share Analysis, by Application, 2023
  • Figure 16: Global Blood Transfusion Diagnostics Market Share Analysis, by Application, 2034
  • Figure 17: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 18: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Grouping, 2020-2034
  • Figure 19: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Grouping, 2023 and 2034
  • Figure 20: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Disease Screening, 2020-2034
  • Figure 21: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Disease Screening, 2023 and 2034
  • Figure 22: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 23: Global Blood Transfusion Diagnostics Market Share Analysis, by End-user, 2023
  • Figure 24: Global Blood Transfusion Diagnostics Market Share Analysis, by End-user, 2034
  • Figure 25: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 26: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Banks, 2020-2034
  • Figure 27: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Banks, 2023 and 2034
  • Figure 28: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Hospitals, 2020-2034
  • Figure 29: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Hospitals, 2023 and 2034
  • Figure 30: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Donation / Transfusion Centers, 2020-2034
  • Figure 31: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Donation / Transfusion Centers, 2023 and 2034
  • Figure 32: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Others, 2020-2034
  • Figure 33: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 34: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 35: Global Blood Transfusion Diagnostics Market Share Analysis, by Region, 2023
  • Figure 36: Global Blood Transfusion Diagnostics Market Share Analysis, by Region, 2034
  • Figure 37: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 38: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 39: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 40: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 41: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 42: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 43: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 44: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 45: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 46: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 47: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 48: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 49: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 50: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 51: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 52: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 53: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 54: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 55: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 56: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 57: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 59: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 60: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 61: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 62: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 63: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 64: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 65: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 66: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 67: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 69: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 70: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 71: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 72: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 74: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 75: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 76: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 77: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 78: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 79: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 80: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 81: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 82: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL85892

Blood Transfusion Diagnostics Market - Scope of Report

TMR's report on the global blood transfusion diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global blood transfusion diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood transfusion diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the blood transfusion diagnostics market.

Market Snapshot
Market Value in 2023US$ 4.6 Bn
Market Value in 2034US$ 7.7 Bn
CAGR4.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood transfusion diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood transfusion diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood transfusion diagnostics market.

The report delves into the competitive landscape of the global blood transfusion diagnostics market. Key players operating in the global blood transfusion diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global blood transfusion diagnostics market profiled in this report.

Key Questions Answered in Global blood transfusion diagnostics Market Report:

  • What is the sales/revenue generated by blood transfusion diagnostics across all regions during the forecast period?
  • What are the opportunities in the global blood transfusion diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Blood Transfusion Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global blood transfusion diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global blood transfusion diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood transfusion diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Transfusion Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Epidemiology of Blood Disorders and Prevalence of Blood Transfusion Events
  • 5.2. Blood Transfusion Products Pricing Analysis
  • 5.3. Government Procurement Policies of Blood Transfusion Diagnostics
  • 5.4. Key Industry Events (Partnerships, Collaborations, Product Approvals, Mergers and Acquisitions, Funding and investments)
  • 5.5. Impact of COVID-19 Pandemic

6. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2034
    • 6.3.1. Instruments
      • 6.3.1.1. Blood Grouping Instruments
      • 6.3.1.2. Others
    • 6.3.2. Kits and Reagents
      • 6.3.2.1. Blood Grouping Kits and Reagents
      • 6.3.2.2. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Blood Grouping
      • 7.3.1.1. ABO Blood Grouping
      • 7.3.1.2. Rh Blood Grouping
      • 7.3.1.3. Red Blood Cell Antibody Screening
      • 7.3.1.4. Extended Phenotyping
      • 7.3.1.5. Cross Matching Tests
    • 7.3.2. Disease Screening
      • 7.3.2.1. Molecular Disease Screening
      • 7.3.2.2. Serological Disease Screening
  • 7.4. Market Attractiveness By Application

8. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Blood Banks
    • 8.3.2. Blood Donation / Transfusion Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness By End-user

9. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Blood Transfusion Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020-2034
    • 10.2.1. Instruments
      • 10.2.1.1. Blood Grouping Instruments
      • 10.2.1.2. Others
    • 10.2.2. Kits and Reagents
      • 10.2.2.1. Blood Grouping Kits and Reagents
      • 10.2.2.2. Others
  • 10.3. Market Value Forecast By Application, 2020-2034
    • 10.3.1. Blood Grouping
      • 10.3.1.1. ABO Blood Grouping
      • 10.3.1.2. Rh Blood Grouping
      • 10.3.1.3. Red Blood Cell Antibody Screening
      • 10.3.1.4. Extended Phenotyping
      • 10.3.1.5. Cross Matching Tests
    • 10.3.2. Disease Screening
      • 10.3.2.1. Molecular Disease Screening
      • 10.3.2.2. Serological Disease Screening
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Blood Banks
    • 10.4.2. Blood Donation / Transfusion Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020-2034
    • 11.2.1. Instruments
      • 11.2.1.1. Blood Grouping Instruments
      • 11.2.1.2. Others
    • 11.2.2. Kits and Reagents
      • 11.2.2.1. Blood Grouping Kits and Reagents
      • 11.2.2.2. Others
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Blood Grouping
      • 11.3.1.1. ABO Blood Grouping
      • 11.3.1.2. Rh Blood Grouping
      • 11.3.1.3. Red Blood Cell Antibody Screening
      • 11.3.1.4. Extended Phenotyping
      • 11.3.1.5. Cross Matching Tests
    • 11.3.2. Disease Screening
      • 11.3.2.1. Molecular Disease Screening
      • 11.3.2.2. Serological Disease Screening
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Blood Banks
    • 11.4.2. Blood Donation / Transfusion Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast By Country, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country

12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2034
    • 12.2.1. Instruments
      • 12.2.1.1. Blood Grouping Instruments
      • 12.2.1.2. Others
    • 12.2.2. Kits and Reagents
      • 12.2.2.1. Blood Grouping Kits and Reagents
      • 12.2.2.2. Others
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Blood Grouping
      • 12.3.1.1. ABO Blood Grouping
      • 12.3.1.2. Rh Blood Grouping
      • 12.3.1.3. Red Blood Cell Antibody Screening
      • 12.3.1.4. Extended Phenotyping
      • 12.3.1.5. Cross Matching Tests
    • 12.3.2. Disease Screening
      • 12.3.2.1. Molecular Disease Screening
      • 12.3.2.2. Serological Disease Screening
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Blood Banks
    • 12.4.2. Blood Donation / Transfusion Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast By Country, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country

13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2034
    • 13.2.1. Instruments
      • 13.2.1.1. Blood Grouping Instruments
      • 13.2.1.2. Others
    • 13.2.2. Kits and Reagents
      • 13.2.2.1. Blood Grouping Kits and Reagents
      • 13.2.2.2. Others
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Blood Grouping
      • 13.3.1.1. ABO Blood Grouping
      • 13.3.1.2. Rh Blood Grouping
      • 13.3.1.3. Red Blood Cell Antibody Screening
      • 13.3.1.4. Extended Phenotyping
      • 13.3.1.5. Cross Matching Tests
    • 13.3.2. Disease Screening
      • 13.3.2.1. Molecular Disease Screening
      • 13.3.2.2. Serological Disease Screening
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Blood Banks
    • 13.4.2. Blood Donation / Transfusion Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast By Country, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country

14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2034
    • 14.2.1. Instruments
      • 14.2.1.1. Blood Grouping Instruments
      • 14.2.1.2. Others
    • 14.2.2. Kits and Reagents
      • 14.2.2.1. Blood Grouping Kits and Reagents
      • 14.2.2.2. Others
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Blood Grouping
      • 14.3.1.1. ABO Blood Grouping
      • 14.3.1.2. Rh Blood Grouping
      • 14.3.1.3. Red Blood Cell Antibody Screening
      • 14.3.1.4. Extended Phenotyping
      • 14.3.1.5. Cross Matching Tests
    • 14.3.2. Disease Screening
      • 14.3.2.1. Molecular Disease Screening
      • 14.3.2.2. Serological Disease Screening
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Blood Banks
    • 14.4.2. Blood Donation / Transfusion Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast By Country, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Grifols, S.A.
      • 15.2.1.1. Company Overview
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. Business Strategies
      • 15.2.1.5. Recent Developments
    • 15.2.2. Werfen, S.A.
      • 15.2.2.1. Company Overview
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. Business Strategies
      • 15.2.2.5. Recent Developments
    • 15.2.3. QuidelOrtho Corporation
      • 15.2.3.1. Company Overview
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. Business Strategies
      • 15.2.3.5. Recent Developments
    • 15.2.4. Abbott
      • 15.2.4.1. Company Overview
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. Business Strategies
      • 15.2.4.5. Recent Developments
    • 15.2.5. Bio-Rad Laboratories Inc.
      • 15.2.5.1. Company Overview
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. Business Strategies
      • 15.2.5.5. Recent Developments
    • 15.2.6. F. Hoffman La Roche Ltd.
      • 15.2.6.1. Company Overview
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. Business Strategies
      • 15.2.6.5. Recent Developments
    • 15.2.7. AliveDx Holdings Finance Company Ltd
      • 15.2.7.1. Company Overview
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. Business Strategies
      • 15.2.7.5. Recent Developments
    • 15.2.8. BAG Diagnostics GmbH
      • 15.2.8.1. Company Overview
      • 15.2.8.2. Financial Overview
      • 15.2.8.3. Product Portfolio
      • 15.2.8.4. Business Strategies
      • 15.2.8.5. Recent Developments
    • 15.2.9. Diasorin S.p.A.
      • 15.2.9.1. Company Overview
      • 15.2.9.2. Financial Overview
      • 15.2.9.3. Product Portfolio
      • 15.2.9.4. Business Strategies
      • 15.2.9.5. Recent Developments
    • 15.2.10. Prestige Diagnostics U.K. Ltd.
      • 15.2.10.1. Company Overview
      • 15.2.10.2. Financial Overview
      • 15.2.10.3. Product Portfolio
      • 15.2.10.4. Business Strategies
      • 15.2.10.5. Recent Developments
    • 15.2.11. Atlas Medical GmbH
      • 15.2.11.1. Company Overview
      • 15.2.11.2. Financial Overview
      • 15.2.11.3. Product Portfolio
      • 15.2.11.4. Business Strategies
      • 15.2.11.5. Recent Developments
    • 15.2.12. Lorne Laboratories Limited
      • 15.2.12.1. Company Overview
      • 15.2.12.2. Financial Overview
      • 15.2.12.3. Product Portfolio
      • 15.2.12.4. Business Strategies
      • 15.2.12.5. Recent Developments